Want to join the conversation?
Medical technology company $BDX posted 2Q16 net income of $338MM or $1.56 per diluted share vs. $216MM or $1.08 per diluted share in 2Q15. Adjusted diluted EPS rose 35.4% to $2.18 for the quarter. 2Q16 revenues rose 49.6% to $3.067Bil vs. 2Q15, helped by increased revenues of 93.1% in BD Medical segment during the quarter.
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."